• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

School vaccination program protects students and families

Article

Investigators evaluated the feasibility and effectiveness of a school-based influenza immunization program in an unblinded pilot study conducted in Maryland. Vaccination with a live attenuated intranasal influenza vaccine (FluMist) was offered to healthy students in one elementary school but not in two control schools. Investigators then compared health outcomes in the households of students in the intervention school with those in households of students in the two elementary schools where the vaccine was not offered.

Approximately 40% (185) of students in the intervention school received the offered vaccine; more than half of those who accepted the offer were vaccinated three weeks or less before the outbreak of influenza. Students in the intervention school, and the people with whom they lived, had fewer medical visits, purchased fewer medications, and missed fewer workdays and school days than students in the control schools and members of their households.

In addition, within the intervention school, the increase in the rate of absenteeism during the outbreak was significantly smaller for students who were vaccinated with the study vaccine than for the students who were not (King JC et al: Pediatrics 2005;116:e868).

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.